Hepatitis D Market
According to Intent Market Research, the Hepatitis D Market is expected to grow from USD 20.3 Billion in 2024-e at a CAGR of 7.1% to touch USD 30.6 Billion by 2030. The Hepatitis D Market is dominated by key players such as, Gilead Sciences, Bristol-Myers Squibb, AbbVie, Merck & Co., Johnson & Johnson, and GlaxoSmithKline (GSK).